AR and posterior cortical atrophy: Patrawala et al. reported that CD44+ PCa cells have higher proliferative, tumorigenic, and metastatic potentials than CD44− PCa cells (Patrawala et al., 2006), and showed that androgen receptor (AR)-negative CD44+ PCa cells differentiate into AR-positive CD44− PCa cells.